Taita Chemical Company Past Earnings Performance
Past criteria checks 0/6
Taita Chemical Company's earnings have been declining at an average annual rate of -2.4%, while the Chemicals industry saw earnings growing at 6.2% annually. Revenues have been declining at an average rate of 2.7% per year.
Key information
-2.4%
Earnings growth rate
-2.4%
EPS growth rate
| Chemicals Industry Growth | 7.9% |
| Revenue growth rate | -2.7% |
| Return on equity | -4.1% |
| Net Margin | -1.8% |
| Next Earnings Update | 07 May 2024 |
Recent past performance updates
Recent updates
Returns On Capital Are A Standout For Taita Chemical Company (TPE:1309)
Apr 20
Is Taita Chemical Company, Ltd. (TPE:1309) A Smart Choice For Dividend Investors?
Apr 05Taita Chemical Company's (TPE:1309) Wonderful 502% Share Price Increase Shows How Capitalism Can Build Wealth
Mar 21Estimating The Intrinsic Value Of Taita Chemical Company, Ltd. (TPE:1309)
Mar 03Does Taita Chemical Company (TPE:1309) Have A Healthy Balance Sheet?
Feb 10Could The Market Be Wrong About Taita Chemical Company, Ltd. (TPE:1309) Given Its Attractive Financial Prospects?
Jan 23
Will Taita Chemical Company (TPE:1309) Become A Multi-Bagger?
Jan 06Is There More To The Story Than Taita Chemical Company's (TPE:1309) Earnings Growth?
Dec 19Introducing Taita Chemical Company (TPE:1309), The Stock That Soared 365% In The Last Five Years
Dec 02Revenue & Expenses BreakdownBeta
How Taita Chemical Company makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 15,205 | -274 | 884 | 16 |
| 30 Sep 23 | 14,988 | -203 | 939 | 15 |
| 30 Jun 23 | 15,695 | -95 | 1,119 | 15 |
| 31 Mar 23 | 17,123 | 81 | 1,338 | 15 |
| 31 Dec 22 | 18,084 | 412 | 1,519 | 15 |
| 30 Sep 22 | 19,549 | 905 | 1,565 | 15 |
| 30 Jun 22 | 20,218 | 1,238 | 1,425 | 16 |
| 31 Mar 22 | 20,771 | 1,620 | 1,273 | 17 |
| 31 Dec 21 | 20,771 | 1,850 | 1,120 | 19 |
| 30 Sep 21 | 20,292 | 2,190 | 997 | 19 |
| 30 Jun 21 | 19,077 | 2,480 | 888 | 20 |
| 31 Mar 21 | 17,076 | 2,264 | 767 | 20 |
| 31 Dec 20 | 15,498 | 1,920 | 681 | 21 |
| 30 Sep 20 | 14,875 | 1,212 | 651 | 22 |
| 30 Jun 20 | 15,115 | 563 | 648 | 24 |
| 31 Mar 20 | 16,030 | 348 | 681 | 25 |
| 31 Dec 19 | 17,672 | 398 | 706 | 25 |
| 30 Sep 19 | 18,563 | 140 | 720 | 24 |
| 30 Jun 19 | 19,977 | 131 | 716 | 26 |
| 31 Mar 19 | 21,442 | 214 | 744 | 24 |
| 31 Dec 18 | 21,684 | 208 | 743 | 23 |
| 30 Sep 18 | 22,060 | 627 | 744 | 24 |
| 30 Jun 18 | 21,472 | 858 | 780 | 21 |
| 31 Mar 18 | 20,145 | 601 | 765 | 21 |
| 31 Dec 17 | 19,821 | 502 | 736 | 21 |
| 30 Sep 17 | 19,051 | 361 | 746 | 20 |
| 30 Jun 17 | 17,704 | 84 | 709 | 20 |
| 31 Mar 17 | 17,248 | 162 | 681 | 19 |
| 31 Dec 16 | 16,419 | 121 | 695 | 18 |
| 30 Sep 16 | 15,551 | -6 | 684 | 18 |
| 30 Jun 16 | 15,779 | -142 | 675 | 18 |
| 31 Mar 16 | 16,643 | 35 | 684 | 18 |
| 31 Dec 15 | 17,028 | 68 | 708 | 19 |
| 30 Sep 15 | 18,213 | -136 | 706 | 19 |
| 30 Jun 15 | 19,950 | -66 | 733 | 20 |
| 31 Mar 15 | 20,645 | -336 | 731 | 19 |
| 31 Dec 14 | 20,934 | -631 | 707 | 19 |
| 30 Sep 14 | 21,247 | -484 | 707 | 21 |
| 30 Jun 14 | 21,381 | -380 | 690 | 21 |
| 31 Mar 14 | 21,413 | -248 | 672 | 22 |
| 31 Dec 13 | 21,439 | 17 | 657 | 23 |
| 30 Sep 13 | 20,860 | 113 | 662 | 24 |
| 30 Jun 13 | 20,137 | 205 | 694 | 25 |
Quality Earnings: 1309 is currently unprofitable.
Growing Profit Margin: 1309 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1309 is unprofitable, and losses have increased over the past 5 years at a rate of 2.4% per year.
Accelerating Growth: Unable to compare 1309's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 1309 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-20.9%).
Return on Equity
High ROE: 1309 has a negative Return on Equity (-4.11%), as it is currently unprofitable.